Historic TAILORx Breast Cancer Clinical Trial Reaches Patient Accrual Goal

Links shared publicly online about this topic.

688
total visits

Historic TAILORx Breast Cancer Clinical Trial Reaches Patient Accrual Goal

Are some women with breast cancer being over-treated with chemotherapy? Breast cancer experts are completing an important milestone this month in their research to answer this question, as they complete accrual of over 10,000 women with early stage breast cancer to the TAILORx clinical trial. TAILORx or "Trial Assigning IndividuaLized Options for Treatment (Rx)", is a clinical research trial for women with early-stage breast cancer.

View full resource at prweb.com

Tags: Cancer, Chemotherapy, Breast Cancer, Clinical Trial, Women's Health

Most Recently Shared on December 1, 2010 at 3:12 am By:

David Flores - Einstein College of Medicine

More on TailorX #breast cancer trial. http://bit.ly/fd9P1K Einstein-Montefiore doc says results could spare 20k women/yr fr chemo. #MDchat

2 years ago...

Retweet

Favorite

Historic TAILORx Breast Cancer Clinical Trial Reaches Patient Accrual Goal | Page 2 of 2

sfgate.com — “Philadelphia, PA (PRWEB) October 25, 2010 Are some women with breast cancerbeing over-treated with chemotherapy? Breast cancer experts are completing an important milestone this month in their research to answer this...” View full resource at sfgate.com